Would their PFS data they already submitted be enough, with their SPA based on PFS?
What would have been the reason to call the ODAC in the first place? SAEs? Its not as if there was only a 2 week difference between the drug and placebo (eg ridaforolimus)....the Cabo arm showed quite a large improvement in PFS over the control.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.